Tag: high-grade B-cell lymphoma treatment

Home / high-grade B-cell lymphoma treatment

Categories

Polatuzumab vedotin-piiq is approved by USFDA for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

May 2023: For adult patients with high-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), or diffuse large B-cell lymphoma (DLBCL) who have not previously received treatment and who have an...
high-grade-b-cell-lymphoma-treatment

Scan the code